Identification of a Homozygous Variant in the CYP21A2 Gene by Next-Generation Sequencing Analysis of Circulating Cell-Free Fetal DNA
Genes · 2025
DOI: 10.3390/genes16030311 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Nadia Petrillo und 13 weiteren Autor:innen. Beteiligte Einrichtung: AMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy. Hauptthemen laut MEDLINE: Steroid 21-Hydroxylase, Adrenal Hyperplasia, Congenital, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by mutations in the CYP21A2 gene associated with 21-hydroxylase deficiency and increased levels of adrenal androgens. Affected females are at risk of ambiguous genitalia, while affected males show sexual precocity. Here, we present a case of a newborn female patient, characterized by ambiguous genitalia and previously identified as low risk for common aneuploidies by non-invasive prenatal testing (NIPT).
Methods
We performed a NIPT, which showed a 46, XX genotype, confirmed by karyotype on the newborn’s DNA extracted lymphocytes. For clinical suspicion of CAH, we performed reverse dot blot and Multiple Ligation-dependent Probe Amplification (MLPA) of the CYP21A2 gene on the patients and her parents’ DNA. Then, we performed on mother’s plasma NGS analysis with an in-house developed panel of genes for monogenic diseases, including the CYP21A2 gene.
Results
Reverse dot blot and MLPA detected the presence of the c.290-13A/C>G (I2 splice) mutation in heterozygosity in the parents and in homozygosity in the child, respectively. NGS detected the c.290-13A/C>G (I2splice) mutation in cell-free fetal DNA (cfDNA) in mother’s plasma with a variant allele frequency (VAF) of 67% with a fetal fraction (FF) of 5%. This latter suggests the presence of the variant both in the mother and in newborn cfDNA.
Conclusions
The study reinforces the hypothesis that cfDNA can be used to identify point mutations, small insertions and/or deletions for the diagnosis of monogenic diseases, reducing the number of invasive tests and the risk of early miscarriages. Early detection of mutations in genes causing sexual development disorders could make it possible to start therapy in the womb.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AMES, Centro Polidiagnostico Strumentale s.r.l., Via Padre Carmine Fico 24, 80013 Casalnuovo Di Napoli, Italy.
- CEINGE Biotecnologie Avanzate Franco Salvatore S.c.a.r.l., 80145 Naples, Italy.
- Clinica Villa dei Fiori, Acerra, 80011 Naples, Italy.
ORCID-Profile: Nadia Petrillo, Giovanni Savarese
Zitieren
APA
Petrillo, N., Marcella, S., Sirica, R., Ianniello, M., Ruggiero, R., Mori, A., Castiello, R., Ramiro, C., D'Angelo, R., Pennacchio, G., Barletta, E., Passaro, R., Fico, A., & Savarese, G. (2025). Identification of a Homozygous Variant in the CYP21A2 Gene by Next-Generation Sequencing Analysis of Circulating Cell-Free Fetal DNA. Genes. https://doi.org/10.3390/genes16030311
Vancouver
Petrillo N, Marcella S, Sirica R, Ianniello M, Ruggiero R, Mori A, et al. Identification of a Homozygous Variant in the CYP21A2 Gene by Next-Generation Sequencing Analysis of Circulating Cell-Free Fetal DNA. Genes. 2025. doi:10.3390/genes16030311
BibTeX
@article{Petrillo2025,
author = {Petrillo, Nadia and Marcella, Simone and Sirica, Roberto and Ianniello, Monica and Ruggiero, Raffaella and Mori, Alessio and Castiello, Rosa and Ramiro, Cristina and D'Angelo, Rossana and Pennacchio, Giuliano and Barletta, Ermanno and Passaro, Roberto and Fico, Antonio and Savarese, Giovanni},
title = {Identification of a Homozygous Variant in the CYP21A2 Gene by Next-Generation Sequencing Analysis of Circulating Cell-Free Fetal DNA},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16030311}
}
EUVIMED